Business Description
Galectin Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US3632252025
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | -2.97 | |||||
Debt-to-Equity | -1.14 | |||||
Debt-to-EBITDA | -2.32 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.9 | |||||
3-Year EPS without NRI Growth Rate | -21.4 | |||||
3-Year FCF Growth Rate | -14.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | -20.46 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.9 | |||||
9-Day RSI | 47.56 | |||||
14-Day RSI | 49.59 | |||||
6-1 Month Momentum % | -31.89 | |||||
12-1 Month Momentum % | 34.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.87 | |||||
Quick Ratio | 1.87 | |||||
Cash Ratio | 1.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.7 | |||||
Shareholder Yield % | -19.89 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -178.58 | |||||
ROIC % | -2965.02 | |||||
ROC (Joel Greenblatt) % | -5985.44 | |||||
ROCE % | -332.43 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -5.77 | |||||
EV-to-EBITDA | -5.77 | |||||
EV-to-Forward-Revenue | 6.44 | |||||
EV-to-FCF | -7.14 | |||||
Earnings Yield (Greenblatt) % | -17.33 | |||||
FCF Yield % | -20.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Galectin Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.733 | ||
Beta | 1.05 | ||
Volatility % | 72.92 | ||
14-Day RSI | 49.59 | ||
14-Day ATR (€) | 0.074849 | ||
20-Day SMA (€) | 2.406 | ||
12-1 Month Momentum % | 34.76 | ||
52-Week Range (€) | 1.41 - 3.88 | ||
Shares Outstanding (Mil) | 62.28 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Galectin Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Galectin Therapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Galectin Therapeutics Inc Frequently Asked Questions
What is Galectin Therapeutics Inc(FRA:PHPN)'s stock price today?
When is next earnings date of Galectin Therapeutics Inc(FRA:PHPN)?
Does Galectin Therapeutics Inc(FRA:PHPN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |